Dasamaps 50 (Dasatinib (50mg))

Dasamaps 50 Tablet contains Dasatinib, an active ingredient that is primarily used in the management of certain types of blood cancers, particularly chronic myeloid leukaemia (CML) and acute lymphoblastic leukaemia (ALL). It works by targeting specific proteins in cancer cells, which helps to slow their growth and limit the spread of the disease, thereby supporting patients in their treatment journey.

Dasatinib functions at a cellular level by inhibiting certain tyrosine kinases, enzymes that play a role in the signaling pathways that drive cancer cell division. By blocking these enzymes, Dasamaps helps to interfere with the cancer cells’ ability to multiply, offering a strategic approach in the fight against blood cancers.

To maintain the effectiveness of Dasamaps, it is recommended to store the tablets in a cool, dry place, away from direct sunlight and moisture. It’s important to keep the medication out of reach of children. Consistency is key in usage, so try to take it as prescribed by a healthcare professional. Additionally, inform your doctor about any other medications you are taking, as interactions may occur.

Some common, mild side effects that may arise include headache, nausea, diarrhea, or fatigue. While these side effects can often be manageable, it’s essential to keep your healthcare provider informed about any unusual experiences during treatment.

This is general information, not a substitute for medical advice. Always consult a doctor/pharmacist and read the package leaflet.